Liver transplantation for alcoholic liver disease

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Patients with end-stage alcoholic liver disease should be considered for liver transplantation. A careful pretransplant evaluation must be undertaken to assess for both medical and psychiatric factors that will continue to require attention following transplantation. Although most programs require at least 6 months of ethanol abstinence before consideration of liver transplantation, there is little evidence that this conclusively predicts a reduction in recidivism. Most programs continue to exclude those with alcoholic hepatitis. Postoperatively, attention to psychiatric issues, recidivism, compliance, and assessment for tumors, especially squamous cell carcinomas, should be undertaken.

Original languageEnglish (US)
Pages (from-to)171-181
Number of pages11
JournalClinics in liver disease
Volume9
Issue number1
DOIs
StatePublished - Feb 2005

Fingerprint

Alcoholic Liver Diseases
Liver Transplantation
Alcoholic Hepatitis
Advance Directives
End Stage Liver Disease
Compliance
Psychiatry
Squamous Cell Carcinoma
Ethanol
Transplantation
Neoplasms

ASJC Scopus subject areas

  • Hepatology

Cite this

Liver transplantation for alcoholic liver disease. / Zetterman, Rowen K.

In: Clinics in liver disease, Vol. 9, No. 1, 02.2005, p. 171-181.

Research output: Contribution to journalReview article

@article{293084c7533d47758cb2da6d2b681135,
title = "Liver transplantation for alcoholic liver disease",
abstract = "Patients with end-stage alcoholic liver disease should be considered for liver transplantation. A careful pretransplant evaluation must be undertaken to assess for both medical and psychiatric factors that will continue to require attention following transplantation. Although most programs require at least 6 months of ethanol abstinence before consideration of liver transplantation, there is little evidence that this conclusively predicts a reduction in recidivism. Most programs continue to exclude those with alcoholic hepatitis. Postoperatively, attention to psychiatric issues, recidivism, compliance, and assessment for tumors, especially squamous cell carcinomas, should be undertaken.",
author = "Zetterman, {Rowen K}",
year = "2005",
month = "2",
doi = "10.1016/j.cld.2004.10.002",
language = "English (US)",
volume = "9",
pages = "171--181",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Liver transplantation for alcoholic liver disease

AU - Zetterman, Rowen K

PY - 2005/2

Y1 - 2005/2

N2 - Patients with end-stage alcoholic liver disease should be considered for liver transplantation. A careful pretransplant evaluation must be undertaken to assess for both medical and psychiatric factors that will continue to require attention following transplantation. Although most programs require at least 6 months of ethanol abstinence before consideration of liver transplantation, there is little evidence that this conclusively predicts a reduction in recidivism. Most programs continue to exclude those with alcoholic hepatitis. Postoperatively, attention to psychiatric issues, recidivism, compliance, and assessment for tumors, especially squamous cell carcinomas, should be undertaken.

AB - Patients with end-stage alcoholic liver disease should be considered for liver transplantation. A careful pretransplant evaluation must be undertaken to assess for both medical and psychiatric factors that will continue to require attention following transplantation. Although most programs require at least 6 months of ethanol abstinence before consideration of liver transplantation, there is little evidence that this conclusively predicts a reduction in recidivism. Most programs continue to exclude those with alcoholic hepatitis. Postoperatively, attention to psychiatric issues, recidivism, compliance, and assessment for tumors, especially squamous cell carcinomas, should be undertaken.

UR - http://www.scopus.com/inward/record.url?scp=14844289536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844289536&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2004.10.002

DO - 10.1016/j.cld.2004.10.002

M3 - Review article

C2 - 15763235

AN - SCOPUS:14844289536

VL - 9

SP - 171

EP - 181

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 1

ER -